-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
$3.5 Million Bet On Aziyo Biologics? Check Out These 3 Penny Stocks Insiders Are Buying
$3.5 Million Bet On Aziyo Biologics? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones closed almost flat on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Aziyo Biologics
- The Trade: Aziyo Biologics, Inc. (NASDAQ:AZYO) Director Kevin Rakin bought a total of 735,000 shares at an average price of $4.75. To acquire these shares, it cost around $3.49 million.
- What's Happening: Aziyo Biologics recently announced pricing of an $11.2 million public offering of common stock.
- What Aziyo Biologics Does: Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
Genius Brands International
- The Trade: Genius Brands International, Inc. (NASDAQ:GNUS) Director Cynthia Turner-Graham acquired a total of 5,000 shares at an average price of $0.73. The insider spent around $3.67 thousand to buy those shares.
- What's Happening: The company, last month, posted a sharp rise in quarterly sales.
- What Genius Brands International Does: Genius Brands International Inc is a kids media company. It is engaged in developing, producing, marketing, and licensing branded children's entertainment properties and consumer products for media and retail distribution.
Investor Sentiment Drops Further After S&P 500 Falls For Fifth Session
Don't forget to check out our premarket coverage here .
Redwire
- The Trade: Redwire Corporation (NYSE:RDW) Director John Bolton acquired a total of 43,839 shares at an average price of $2.01. To acquire these shares, it cost around $88.12 thousand.
- What's Happening: The company, last month, said revenue increased 14.0% to $37.2 million for the three months ended September 30, 2022.
- What Redwire Does: Redwire Corp is engaged in mission-critical space solutions and reliable components for the next generation space economy, with IP for solar power generation and in-space 3D printing and manufacturing.
The Dow Jones closed almost flat on Wednesday. Investors, meanwhile, focused on some notable insider trades.
道瓊斯週三收盤幾乎平坦。與此同時,投資者專注於一些值得注意的內幕交易。
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
當內部人士購買或出售股票時,表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以認為這是他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是最近一些細價股的著名內幕交易。欲了解更多信息,請查看 本辛加的內幕交易 平台。
Aziyo Biologics
阿齊約生物製劑
- The Trade: Aziyo Biologics, Inc. (NASDAQ:AZYO) Director Kevin Rakin bought a total of 735,000 shares at an average price of $4.75. To acquire these shares, it cost around $3.49 million.
- What's Happening: Aziyo Biologics recently announced pricing of an $11.2 million public offering of common stock.
- What Aziyo Biologics Does: Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
- 貿易: 阿齊優生物製劑股份有限公司 (納斯達克:AZYO) 導演凱文·拉金 買入共 7 萬 5 萬股 平均價格為 4.75 美元。要收購這些股份,其成本約為 349 萬美元。
- 發生了什麼事: 阿齊約生物製劑最近宣布定價 1,120 萬美元的普通股公開發行。
- 阿齊約生物製劑的作用是什麼: Aziyo Biologics Inc 是一家商業階段的再生醫學公司,致力於創造下一代差異化產品並改善接受手術患者的結果,專注於接受植入式醫療設備的患者。
Genius Brands International
天才品牌國際
- The Trade: Genius Brands International, Inc. (NASDAQ:GNUS) Director Cynthia Turner-Graham acquired a total of 5,000 shares at an average price of $0.73. The insider spent around $3.67 thousand to buy those shares.
- What's Happening: The company, last month, posted a sharp rise in quarterly sales.
- What Genius Brands International Does: Genius Brands International Inc is a kids media company. It is engaged in developing, producing, marketing, and licensing branded children's entertainment properties and consumer products for media and retail distribution.
- 貿易: 天才品牌國際有限公司 (納斯達克:GNUS) 導演辛西婭·特納-格雷厄姆 購入總共五千股 平均價格為 0.73 美元。內幕人士花了大約 3.67 萬美元購買這些股票。
- 發生了什麼: 上個月,該公司季度銷售額急劇上升。
- 天才品牌國際做什麼: 天才品牌國際有限公司是一家兒童媒體公司。該公司致力於開發、生產、行銷和授權品牌兒童娛樂財產和消費性產品,用於媒體和零售分銷。
Investor Sentiment Drops Further After S&P 500 Falls For Fifth Session
標普 500 指數第五次下跌後,投資者情緒進一步下跌
Don't forget to check out our premarket coverage here .
別忘了在這裡查看我們的售前保障。
Redwire
红线
- The Trade: Redwire Corporation (NYSE:RDW) Director John Bolton acquired a total of 43,839 shares at an average price of $2.01. To acquire these shares, it cost around $88.12 thousand.
- What's Happening: The company, last month, said revenue increased 14.0% to $37.2 million for the three months ended September 30, 2022.
- What Redwire Does: Redwire Corp is engaged in mission-critical space solutions and reliable components for the next generation space economy, with IP for solar power generation and in-space 3D printing and manufacturing.
- 貿易: 红线公司 紐約證交所代碼:RDW)董事約翰·博爾頓 購入共 43,839 股股份 平均價格為 2.01 美元。要收購這些股票,其成本約為 88.12 萬美元。
- 發生了什麼:該公司上月表示,截至 2022 年 9 月 30 日止三個月的收入增長 14.0%,達到 37.2 百萬美元。
- 紅線做什麼: Redwire Corp 致力於針對下一代太空經濟的關鍵任務空間解決方案和可靠的組件,為太陽能發電和太空 3D 打印和製造提供 IP。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧